IL137836A0 - Methods and compositions for diagnosis of hepatoma - Google Patents

Methods and compositions for diagnosis of hepatoma

Info

Publication number
IL137836A0
IL137836A0 IL13783699A IL13783699A IL137836A0 IL 137836 A0 IL137836 A0 IL 137836A0 IL 13783699 A IL13783699 A IL 13783699A IL 13783699 A IL13783699 A IL 13783699A IL 137836 A0 IL137836 A0 IL 137836A0
Authority
IL
Israel
Prior art keywords
hepatoma
diagnosis
compositions
methods
Prior art date
Application number
IL13783699A
Original Assignee
Oxford Glycosciences Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803138.8A external-priority patent/GB9803138D0/en
Priority claimed from GBGB9803269.1A external-priority patent/GB9803269D0/en
Application filed by Oxford Glycosciences Uk Ltd filed Critical Oxford Glycosciences Uk Ltd
Publication of IL137836A0 publication Critical patent/IL137836A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13783699A 1998-02-13 1999-02-15 Methods and compositions for diagnosis of hepatoma IL137836A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9803138.8A GB9803138D0 (en) 1998-02-13 1998-02-13 Methods and compositions for diagnosis of hepatoma
GBGB9803269.1A GB9803269D0 (en) 1998-02-16 1998-02-16 Methods And Compositions For Diagnosis Of Hepatoma
PCT/GB1999/000458 WO1999041612A1 (en) 1998-02-13 1999-02-15 Methods and compositions for diagnosis of hepatoma

Publications (1)

Publication Number Publication Date
IL137836A0 true IL137836A0 (en) 2001-10-31

Family

ID=26313117

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13783699A IL137836A0 (en) 1998-02-13 1999-02-15 Methods and compositions for diagnosis of hepatoma

Country Status (9)

Country Link
EP (1) EP1055126A1 (en)
JP (1) JP2002503813A (en)
KR (1) KR20010040970A (en)
CN (1) CN1295668A (en)
AU (1) AU2534999A (en)
CA (1) CA2321160A1 (en)
HU (1) HUP0101285A2 (en)
IL (1) IL137836A0 (en)
WO (1) WO1999041612A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919597D0 (en) * 1999-08-18 1999-10-20 Oxford Glycosciences Uk Ltd Methods and compositions for diagnosis of hepatoma
JP2003508754A (en) * 1999-09-02 2003-03-04 プロティオーム・サイエンシィズ・ピーエルシー Methods and compositions relating to weight and eating disorders
IL153189A0 (en) 2000-06-19 2003-06-24 Correlogic Systems Inc Heuristic method of classification
KR101054732B1 (en) 2000-07-18 2011-08-05 더 유나이티드 스테이츠 오브 아메리카 애즈 리프리젠티드 바이 더 세크레터리 오브 더 디파트먼트 오브 헬쓰 앤드 휴먼 써비시즈 How to Identify Biological Conditions Based on Hidden Patterns of Biological Data
AU2002225219A1 (en) * 2001-01-26 2002-08-06 Oxford Glycosciences (Uk) Ltd Diagnosis and treatment of multiple sclerosis
WO2004011905A2 (en) 2002-07-29 2004-02-05 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
JP4774534B2 (en) 2003-12-11 2011-09-14 アングーク ファーマシューティカル カンパニー，リミティド A diagnostic method for biological status through the use of a centralized adaptive model and remotely manipulated sample processing
SG182976A1 (en) 2007-06-29 2012-08-30 Ahngook Pharmaceutical Co Ltd Predictive markers for ovarian cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06105257B2 (en) * 1984-08-07 1994-12-21 協和メデックス株式会社 Cancer measurement kit
EP0531080A3 (en) * 1991-09-04 1993-12-29 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein
EP0857780A4 (en) * 1995-09-14 2001-12-05 Sumitomo Electric Industries Novel proteins remarkably expressed in liver cancer, genes encoding the same, antibodies against the same, and method for detecting the expression of the same
JPH09203734A (en) * 1996-01-26 1997-08-05 Sumitomo Electric Ind Ltd Antiserum, antibody, ligand, and method for detecting the same
AU8267398A (en) * 1997-06-26 1999-01-19 Regents Of The University Of Michigan, The Method for identification of tumor antigens with autoantibodies in serum

Also Published As

Publication number Publication date
WO1999041612A1 (en) 1999-08-19
CN1295668A (en) 2001-05-16
HUP0101285A2 (en) 2001-08-28
AU2534999A (en) 1999-08-30
JP2002503813A (en) 2002-02-05
EP1055126A1 (en) 2000-11-29
KR20010040970A (en) 2001-05-15
CA2321160A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
PL348817A1 (en) Compositions and methods for the treatment of anorectal disorders
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
EP0808324A4 (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
PL341566A1 (en) Oral composition of yttraconasole preparation and method of obtaining same
PL344589A1 (en) COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE
IL140214A0 (en) Butterlike compositions and methods of manufacturing same
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
GB0015235D0 (en) Compositions for the treatment of skin and anorectal conditions
EP1076547A4 (en) Derivatives of arabinogalactan and compositions including the same
AU4322999A (en) Methods and compositions for diagnosing tauopathies
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
EP1056456A4 (en) R-lansoprazole compositions and methods
EP1056457A4 (en) S-lansoprazole compositions and methods
GB9805477D0 (en) Methods and compositions for diagnosis of rheumatoid arthritis
EP0934427A4 (en) Rh blood group antigen compositions and methods of use
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
IL141426A0 (en) Compositions and methods for the treatment of tumor
EP1139981A4 (en) Compositions and methods of using the same
IL143212A0 (en) Compositions and methods for the treatment of tumor
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
GB9805913D0 (en) Diagnosis of ms
AU2433100A (en) Methods and compositions for the fixation of trace amounts of radiocaesium
GB9803269D0 (en) Methods And Compositions For Diagnosis Of Hepatoma